

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 8.94517663 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 8.94517663 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 8.16585049 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.51740792 |
| 5 | negative T cell selection (GO:0043383) | 6.01658536 |
| 6 | negative thymic T cell selection (GO:0045060) | 5.80682542 |
| 7 | response to type I interferon (GO:0034340) | 5.58900638 |
| 8 | cellular response to type I interferon (GO:0071357) | 5.51670277 |
| 9 | type I interferon signaling pathway (GO:0060337) | 5.51670277 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.32099302 |
| 11 | negative regulation of cell killing (GO:0031342) | 5.30147204 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.30147204 |
| 13 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 5.21242129 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.14472096 |
| 15 | positive thymic T cell selection (GO:0045059) | 5.09709202 |
| 16 | interferon-gamma production (GO:0032609) | 5.08418827 |
| 17 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.99580664 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 4.87646020 |
| 19 | positive T cell selection (GO:0043368) | 4.85143432 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.78957010 |
| 21 | T cell selection (GO:0045058) | 4.77281779 |
| 22 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.76487717 |
| 23 | regulation of T cell tolerance induction (GO:0002664) | 4.76045602 |
| 24 | T cell migration (GO:0072678) | 4.70364904 |
| 25 | thymic T cell selection (GO:0045061) | 4.70116361 |
| 26 | cellular response to interleukin-15 (GO:0071350) | 4.64734811 |
| 27 | cellular response to interferon-beta (GO:0035458) | 4.61042135 |
| 28 | response to interleukin-15 (GO:0070672) | 4.60570348 |
| 29 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.58617568 |
| 30 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.34604111 |
| 31 | regulation of regulatory T cell differentiation (GO:0045589) | 4.27512010 |
| 32 | negative regulation of interleukin-12 production (GO:0032695) | 4.26853666 |
| 33 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 4.26425830 |
| 34 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.20183056 |
| 35 | leukocyte aggregation (GO:0070486) | 4.04764352 |
| 36 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.00478972 |
| 37 | positive regulation of type 2 immune response (GO:0002830) | 3.97112914 |
| 38 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.92903438 |
| 39 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.92066506 |
| 40 | T cell receptor signaling pathway (GO:0050852) | 3.89422721 |
| 41 | positive regulation of humoral immune response (GO:0002922) | 3.88948917 |
| 42 | T cell costimulation (GO:0031295) | 3.87678257 |
| 43 | response to interferon-beta (GO:0035456) | 3.84783387 |
| 44 | lymphocyte costimulation (GO:0031294) | 3.82859324 |
| 45 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.80951492 |
| 46 | immunoglobulin mediated immune response (GO:0016064) | 3.78498129 |
| 47 | positive regulation of interleukin-2 production (GO:0032743) | 3.74814936 |
| 48 | positive regulation of isotype switching (GO:0045830) | 3.69757091 |
| 49 | regulation of response to interferon-gamma (GO:0060330) | 3.65973379 |
| 50 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.60068763 |
| 51 | regulation of chronic inflammatory response (GO:0002676) | 3.59274309 |
| 52 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.58267075 |
| 53 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.57751743 |
| 54 | NIK/NF-kappaB signaling (GO:0038061) | 3.57114637 |
| 55 | tryptophan catabolic process (GO:0006569) | 3.55728069 |
| 56 | indole-containing compound catabolic process (GO:0042436) | 3.55728069 |
| 57 | indolalkylamine catabolic process (GO:0046218) | 3.55728069 |
| 58 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.55721603 |
| 59 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.55721603 |
| 60 | modulation by symbiont of host immune response (GO:0052553) | 3.55721603 |
| 61 | positive regulation by symbiont of host defense response (GO:0052509) | 3.55721603 |
| 62 | modulation by symbiont of host defense response (GO:0052031) | 3.55721603 |
| 63 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.55721603 |
| 64 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.53550187 |
| 65 | myeloid dendritic cell differentiation (GO:0043011) | 3.52848363 |
| 66 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.52514615 |
| 67 | positive regulation of defense response to virus by host (GO:0002230) | 3.50492007 |
| 68 | regulation of tolerance induction (GO:0002643) | 3.49918698 |
| 69 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.49543556 |
| 70 | myeloid dendritic cell activation (GO:0001773) | 3.46529317 |
| 71 | response to interferon-alpha (GO:0035455) | 3.42994283 |
| 72 | positive regulation of antigen processing and presentation (GO:0002579) | 3.42650589 |
| 73 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.42252362 |
| 74 | regulation of type 2 immune response (GO:0002828) | 3.41743951 |
| 75 | kynurenine metabolic process (GO:0070189) | 3.40467448 |
| 76 | alpha-beta T cell activation (GO:0046631) | 3.39078014 |
| 77 | macrophage activation involved in immune response (GO:0002281) | 3.37881101 |
| 78 | lymphocyte chemotaxis (GO:0048247) | 3.33752077 |
| 79 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.31843435 |
| 80 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.31821553 |
| 81 | positive regulation of interferon-alpha production (GO:0032727) | 3.31241779 |
| 82 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.30570714 |
| 83 | positive regulation of B cell mediated immunity (GO:0002714) | 3.30570714 |
| 84 | positive regulation of DNA recombination (GO:0045911) | 3.29401966 |
| 85 | detection of other organism (GO:0098543) | 3.28597769 |
| 86 | tolerance induction (GO:0002507) | 3.28235475 |
| 87 | cellular response to interferon-gamma (GO:0071346) | 3.25997917 |
| 88 | response to interferon-gamma (GO:0034341) | 3.25339252 |
| 89 | regulation of interleukin-12 production (GO:0032655) | 3.23909820 |
| 90 | positive regulation of tolerance induction (GO:0002645) | 3.23899807 |
| 91 | activated T cell proliferation (GO:0050798) | 3.23630360 |
| 92 | alpha-beta T cell differentiation (GO:0046632) | 3.22879406 |
| 93 | mast cell activation (GO:0045576) | 3.22034064 |
| 94 | regulation of interferon-alpha production (GO:0032647) | 3.20438504 |
| 95 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.19673635 |
| 96 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.19528371 |
| 97 | response to peptidoglycan (GO:0032494) | 3.17057406 |
| 98 | regulation of isotype switching (GO:0045191) | 3.15008683 |
| 99 | T-helper 1 type immune response (GO:0042088) | 3.14715343 |
| 100 | negative regulation of T cell mediated immunity (GO:0002710) | 3.12319446 |
| 101 | response to protozoan (GO:0001562) | 3.11142358 |
| 102 | negative regulation of type 2 immune response (GO:0002829) | 3.10542430 |
| 103 | regulation of memory T cell differentiation (GO:0043380) | 3.10197990 |
| 104 | detection of bacterium (GO:0016045) | 3.09968266 |
| 105 | natural killer cell activation (GO:0030101) | 3.08776732 |
| 106 | regulation of antigen processing and presentation (GO:0002577) | 3.07466610 |
| 107 | B cell mediated immunity (GO:0019724) | 3.06594494 |
| 108 | negative regulation of viral genome replication (GO:0045071) | 3.06371107 |
| 109 | cellular response to exogenous dsRNA (GO:0071360) | 3.06092950 |
| 110 | T cell proliferation (GO:0042098) | 3.05633321 |
| 111 | interferon-gamma secretion (GO:0072643) | 3.04560080 |
| 112 | cellular response to interferon-alpha (GO:0035457) | 3.04037118 |
| 113 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.03657990 |
| 114 | tryptophan metabolic process (GO:0006568) | 3.03456995 |
| 115 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.02499803 |
| 116 | positive regulation of T cell cytokine production (GO:0002726) | 3.02172944 |
| 117 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.01597575 |
| 118 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.00164931 |
| 119 | positive regulation of interferon-beta production (GO:0032728) | 2.97521784 |
| 120 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.97089406 |
| 121 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.96712239 |
| 122 | leukocyte cell-cell adhesion (GO:0007159) | 2.96679362 |
| 123 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.95904122 |
| 124 | lymphocyte migration (GO:0072676) | 2.94948870 |
| 125 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.94349510 |
| 126 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.94166508 |
| 127 | regulation of alpha-beta T cell activation (GO:0046634) | 2.93959557 |
| 128 | regulation of T-helper cell differentiation (GO:0045622) | 2.93635560 |
| 129 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.93620677 |
| 130 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.92860031 |
| 131 | germinal center formation (GO:0002467) | 2.92621462 |
| 132 | defense response to virus (GO:0051607) | 2.91099398 |
| 133 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90054593 |
| 134 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.89599072 |
| 135 | positive regulation of interleukin-12 production (GO:0032735) | 2.88375614 |
| 136 | defense response to protozoan (GO:0042832) | 2.86755817 |
| 137 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.86640760 |
| 138 | regulation of B cell mediated immunity (GO:0002712) | 2.85741828 |
| 139 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.85405132 |
| 140 | regulation of RIG-I signaling pathway (GO:0039535) | 2.84381635 |
| 141 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.83946999 |
| 142 | T cell homeostasis (GO:0043029) | 2.83728169 |
| 143 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.82154071 |
| 144 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.81423121 |
| 145 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.80320615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.13441012 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.03522020 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.44084339 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.66581757 |
| 5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.25896573 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.04263148 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.05524164 |
| 8 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.74115727 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.50754189 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.18008667 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.16206928 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.98140624 |
| 13 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.98112066 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.80691070 |
| 15 | * MYB_26560356_Chip-Seq_TH2_Human | 2.74355321 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54951820 |
| 17 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.54840849 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.42829418 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.38525687 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 2.23354855 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.16209472 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.98734055 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.88771115 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.82023244 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 1.81758710 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.80597691 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76751815 |
| 28 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.75267299 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.74160612 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.60960634 |
| 31 | MAF_26560356_Chip-Seq_TH2_Human | 1.55928327 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.55219336 |
| 33 | MYC_22102868_ChIP-Seq_BL_Human | 1.52264652 |
| 34 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49754381 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.45055782 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.40538429 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39033613 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.32743632 |
| 39 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.32529067 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31328880 |
| 41 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29018066 |
| 42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.28890725 |
| 43 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28119204 |
| 44 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.27838369 |
| 45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.27522159 |
| 46 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.24759813 |
| 47 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24383163 |
| 48 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.24211459 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22378026 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22376020 |
| 51 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21293993 |
| 52 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21104950 |
| 53 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.20475219 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.17429011 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16885854 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13923537 |
| 57 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12811878 |
| 58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11036275 |
| 59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09717416 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08973682 |
| 61 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08941054 |
| 62 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08407636 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05057651 |
| 64 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02438295 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98773317 |
| 66 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98450928 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98251197 |
| 68 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97872623 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95484449 |
| 70 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94217709 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91369519 |
| 72 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.90953644 |
| 73 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.90903515 |
| 74 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90360295 |
| 75 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.88228217 |
| 76 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88021555 |
| 77 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87562360 |
| 78 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.87343053 |
| 79 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83307837 |
| 80 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82907002 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80174998 |
| 82 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79953815 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.78740759 |
| 84 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.77515940 |
| 85 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.76986597 |
| 86 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76952556 |
| 87 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.76312244 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.75207776 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74723682 |
| 90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.73943429 |
| 91 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.73140991 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 0.72779503 |
| 93 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72108431 |
| 94 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71929598 |
| 95 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.71106882 |
| 96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71084330 |
| 97 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.70702398 |
| 98 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.70418891 |
| 99 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.70205428 |
| 100 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.69538260 |
| 101 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.68932498 |
| 102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.68712885 |
| 103 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.68237597 |
| 104 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.67540422 |
| 105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.67440441 |
| 106 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66406782 |
| 107 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.66070305 |
| 108 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.64504025 |
| 109 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.64135563 |
| 110 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.63397457 |
| 111 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.63037975 |
| 112 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.62804603 |
| 113 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62019684 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61145775 |
| 115 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.61010574 |
| 116 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.58305940 |
| 117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.57580439 |
| 118 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.56094183 |
| 119 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.53590664 |
| 120 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.53555860 |
| 121 | GATA3_26560356_Chip-Seq_TH1_Human | 0.52544076 |
| 122 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.52040984 |
| 123 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.52024285 |
| 124 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.51791865 |
| 125 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.50930097 |
| 126 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.50341547 |
| 127 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.50087044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.72767063 |
| 2 | MP0005671_abnormal_response_to | 4.25976762 |
| 3 | MP0000685_abnormal_immune_system | 4.02625709 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.89928793 |
| 5 | MP0009785_altered_susceptibility_to | 3.63204505 |
| 6 | MP0001790_abnormal_immune_system | 3.47417339 |
| 7 | MP0005387_immune_system_phenotype | 3.47417339 |
| 8 | MP0003724_increased_susceptibility_to | 3.40275429 |
| 9 | MP0002166_altered_tumor_susceptibility | 3.28933842 |
| 10 | MP0001800_abnormal_humoral_immune | 3.23848280 |
| 11 | MP0004510_myositis | 3.22553766 |
| 12 | MP0005000_abnormal_immune_tolerance | 3.08564399 |
| 13 | MP0006082_CNS_inflammation | 2.97941819 |
| 14 | MP0005025_abnormal_response_to | 2.92570353 |
| 15 | MP0002723_abnormal_immune_serum | 2.88803643 |
| 16 | MP0002006_tumorigenesis | 2.78433773 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.72793593 |
| 18 | MP0001819_abnormal_immune_cell | 2.68113906 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.67453572 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.60576608 |
| 21 | MP0003436_decreased_susceptibility_to | 2.60115254 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.33589688 |
| 23 | MP0002398_abnormal_bone_marrow | 2.31833443 |
| 24 | MP0003303_peritoneal_inflammation | 2.29753729 |
| 25 | MP0002419_abnormal_innate_immunity | 2.21576047 |
| 26 | MP0000716_abnormal_immune_system | 2.20174476 |
| 27 | MP0002405_respiratory_system_inflammati | 2.18243966 |
| 28 | MP0004947_skin_inflammation | 2.12075382 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.04929991 |
| 30 | MP0001873_stomach_inflammation | 1.98651569 |
| 31 | MP0001853_heart_inflammation | 1.94208902 |
| 32 | MP0000703_abnormal_thymus_morphology | 1.85148196 |
| 33 | MP0005310_abnormal_salivary_gland | 1.84166493 |
| 34 | MP0002722_abnormal_immune_system | 1.80003167 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.78178764 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.74689996 |
| 37 | MP0003195_calcinosis | 1.72482936 |
| 38 | MP0002429_abnormal_blood_cell | 1.72310886 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.71450866 |
| 40 | MP0003866_abnormal_defecation | 1.69340252 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.65512707 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.53941674 |
| 43 | MP0003448_altered_tumor_morphology | 1.52148847 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.50291283 |
| 45 | MP0000569_abnormal_digit_pigmentation | 1.43635666 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.41957652 |
| 47 | MP0008469_abnormal_protein_level | 1.39730399 |
| 48 | MP0003646_muscle_fatigue | 1.34338881 |
| 49 | MP0002933_joint_inflammation | 1.26067868 |
| 50 | MP0004381_abnormal_hair_follicle | 1.25489193 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.23387850 |
| 52 | MP0001851_eye_inflammation | 1.21880031 |
| 53 | MP0001501_abnormal_sleep_pattern | 1.19622362 |
| 54 | MP0002254_reproductive_system_inflammat | 1.15724892 |
| 55 | MP0005451_abnormal_body_composition | 1.14581131 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.13285275 |
| 57 | MP0009764_decreased_sensitivity_to | 1.12773820 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.06406041 |
| 59 | MP0000858_altered_metastatic_potential | 1.05597156 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.04757735 |
| 61 | MP0008004_abnormal_stomach_pH | 1.04419235 |
| 62 | MP0004808_abnormal_hematopoietic_stem | 1.03422282 |
| 63 | MP0002139_abnormal_hepatobiliary_system | 1.02089138 |
| 64 | MP0009278_abnormal_bone_marrow | 0.97722988 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 0.95833164 |
| 66 | MP0003252_abnormal_bile_duct | 0.93212536 |
| 67 | MP0002009_preneoplasia | 0.92406796 |
| 68 | MP0000343_altered_response_to | 0.92358694 |
| 69 | MP0000604_amyloidosis | 0.91670338 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 0.91229245 |
| 71 | MP0003690_abnormal_glial_cell | 0.90225783 |
| 72 | MP0005058_abnormal_lysosome_morphology | 0.89522497 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 0.88417663 |
| 74 | MP0001545_abnormal_hematopoietic_system | 0.88417663 |
| 75 | MP0005409_darkened_coat_color | 0.88054382 |
| 76 | MP0006054_spinal_hemorrhage | 0.85494865 |
| 77 | MP0003045_fibrosis | 0.83750849 |
| 78 | MP0003806_abnormal_nucleotide_metabolis | 0.81620948 |
| 79 | MP0004782_abnormal_surfactant_physiolog | 0.81324288 |
| 80 | MP0004883_abnormal_blood_vessel | 0.81310395 |
| 81 | MP0005164_abnormal_response_to | 0.80320841 |
| 82 | MP0009763_increased_sensitivity_to | 0.79579512 |
| 83 | MP0009840_abnormal_foam_cell | 0.78833819 |
| 84 | MP0003828_pulmonary_edema | 0.78162874 |
| 85 | MP0001879_abnormal_lymphatic_vessel | 0.77295151 |
| 86 | MP0001348_abnormal_lacrimal_gland | 0.76465621 |
| 87 | MP0000920_abnormal_myelination | 0.74378015 |
| 88 | MP0003191_abnormal_cellular_cholesterol | 0.72539507 |
| 89 | MP0000249_abnormal_blood_vessel | 0.70198863 |
| 90 | MP0003091_abnormal_cell_migration | 0.66854372 |
| 91 | MP0004043_abnormal_pH_regulation | 0.66602719 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.65952625 |
| 93 | MP0005535_abnormal_body_temperature | 0.63043650 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 0.62644400 |
| 95 | MP0000371_diluted_coat_color | 0.61104682 |
| 96 | MP0004130_abnormal_muscle_cell | 0.59044947 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.58670820 |
| 98 | MP0002132_abnormal_respiratory_system | 0.58650862 |
| 99 | MP0004185_abnormal_adipocyte_glucose | 0.58271319 |
| 100 | MP0002693_abnormal_pancreas_physiology | 0.56503058 |
| 101 | MP0002019_abnormal_tumor_incidence | 0.56077354 |
| 102 | MP0000015_abnormal_ear_pigmentation | 0.55864919 |
| 103 | MP0008874_decreased_physiological_sensi | 0.55660902 |
| 104 | MP0001986_abnormal_taste_sensitivity | 0.55573067 |
| 105 | MP0000490_abnormal_crypts_of | 0.54176083 |
| 106 | MP0005266_abnormal_metabolism | 0.53979814 |
| 107 | MP0009765_abnormal_xenobiotic_induced | 0.53943222 |
| 108 | MP0005174_abnormal_tail_pigmentation | 0.53396009 |
| 109 | MP0005023_abnormal_wound_healing | 0.53056597 |
| 110 | MP0005166_decreased_susceptibility_to | 0.52797531 |
| 111 | MP0000383_abnormal_hair_follicle | 0.51689483 |
| 112 | MP0002168_other_aberrant_phenotype | 0.51018331 |
| 113 | MP0005647_abnormal_sex_gland | 0.51011093 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.50904815 |
| 115 | MP0005390_skeleton_phenotype | 0.50260587 |
| 116 | MP0003795_abnormal_bone_structure | 0.49790397 |
| 117 | MP0001216_abnormal_epidermal_layer | 0.49702433 |
| 118 | MP0001663_abnormal_digestive_system | 0.47763478 |
| 119 | MP0001191_abnormal_skin_condition | 0.45479489 |
| 120 | MP0010307_abnormal_tumor_latency | 0.42947445 |
| 121 | MP0008961_abnormal_basal_metabolism | 0.42816721 |
| 122 | MP0002163_abnormal_gland_morphology | 0.42156982 |
| 123 | MP0001881_abnormal_mammary_gland | 0.41226239 |
| 124 | MP0003075_altered_response_to | 0.41154710 |
| 125 | MP0005075_abnormal_melanosome_morpholog | 0.40227326 |
| 126 | MP0009115_abnormal_fat_cell | 0.37972032 |
| 127 | MP0000767_abnormal_smooth_muscle | 0.37214573 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic otitis media (HP:0000389) | 6.52208672 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.03020834 |
| 3 | T lymphocytopenia (HP:0005403) | 6.01860068 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.28664395 |
| 5 | Nasal polyposis (HP:0100582) | 5.26559741 |
| 6 | Recurrent bronchitis (HP:0002837) | 5.21134266 |
| 7 | Recurrent fungal infections (HP:0002841) | 5.11755490 |
| 8 | Recurrent cutaneous fungal infections (HP:0011370) | 4.97995652 |
| 9 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.97995652 |
| 10 | Recurrent viral infections (HP:0004429) | 4.95869215 |
| 11 | Severe combined immunodeficiency (HP:0004430) | 4.92739917 |
| 12 | Abnormality of the nasal mucosa (HP:0000433) | 4.90220839 |
| 13 | Eczematoid dermatitis (HP:0000976) | 4.79913242 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 4.53362339 |
| 15 | Myositis (HP:0100614) | 4.43169185 |
| 16 | Abnormality of T cells (HP:0002843) | 4.37990211 |
| 17 | Combined immunodeficiency (HP:0005387) | 4.37613922 |
| 18 | Stomatitis (HP:0010280) | 4.32668263 |
| 19 | Optic neuritis (HP:0100653) | 4.17651400 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 4.17651400 |
| 21 | Thyroiditis (HP:0100646) | 4.05026205 |
| 22 | Autoimmune hemolytic anemia (HP:0001890) | 4.04858998 |
| 23 | Increased IgM level (HP:0003496) | 3.99002358 |
| 24 | Abnormality of B cell number (HP:0010975) | 3.98340845 |
| 25 | B lymphocytopenia (HP:0010976) | 3.98340845 |
| 26 | Autoimmune thrombocytopenia (HP:0001973) | 3.98299609 |
| 27 | Chronic sinusitis (HP:0011109) | 3.95636975 |
| 28 | Eosinophilia (HP:0001880) | 3.87391174 |
| 29 | Orchitis (HP:0100796) | 3.85650301 |
| 30 | Recurrent abscess formation (HP:0002722) | 3.77949320 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.76186752 |
| 32 | Abnormality of eosinophils (HP:0001879) | 3.67736055 |
| 33 | Vasculitis (HP:0002633) | 3.59034821 |
| 34 | IgG deficiency (HP:0004315) | 3.58267094 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 3.50500105 |
| 36 | Recurrent skin infections (HP:0001581) | 3.47669997 |
| 37 | Hypoplasia of the thymus (HP:0000778) | 3.39651863 |
| 38 | Leukocytosis (HP:0001974) | 3.33921661 |
| 39 | Granulocytopenia (HP:0001913) | 3.32883264 |
| 40 | Meningitis (HP:0001287) | 3.30132544 |
| 41 | Chronic diarrhea (HP:0002028) | 3.28531989 |
| 42 | Spontaneous hematomas (HP:0007420) | 3.25475733 |
| 43 | Hemoptysis (HP:0002105) | 3.23020713 |
| 44 | Recurrent bacterial skin infections (HP:0005406) | 3.13960273 |
| 45 | Pustule (HP:0200039) | 3.09401917 |
| 46 | Agammaglobulinemia (HP:0004432) | 3.07039100 |
| 47 | Prostate neoplasm (HP:0100787) | 3.01903250 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 3.01866084 |
| 49 | Obstructive lung disease (HP:0006536) | 3.01866084 |
| 50 | Hypergammaglobulinemia (HP:0010702) | 3.00971683 |
| 51 | Stomach cancer (HP:0012126) | 2.99152999 |
| 52 | Abnormality of the fingertips (HP:0001211) | 2.99022397 |
| 53 | Pulmonary infiltrates (HP:0002113) | 2.92291843 |
| 54 | Inflammation of the large intestine (HP:0002037) | 2.91678353 |
| 55 | Abnormality of T cell physiology (HP:0011840) | 2.89167152 |
| 56 | Increased IgE level (HP:0003212) | 2.88359682 |
| 57 | Joint swelling (HP:0001386) | 2.86287808 |
| 58 | Bronchitis (HP:0012387) | 2.85812413 |
| 59 | Systemic lupus erythematosus (HP:0002725) | 2.85590639 |
| 60 | Keratoconjunctivitis (HP:0001096) | 2.82519357 |
| 61 | Encephalitis (HP:0002383) | 2.81389025 |
| 62 | Keratoconjunctivitis sicca (HP:0001097) | 2.78722275 |
| 63 | Gastrointestinal inflammation (HP:0004386) | 2.73253219 |
| 64 | IgM deficiency (HP:0002850) | 2.73120363 |
| 65 | Abnormality of macrophages (HP:0004311) | 2.69845379 |
| 66 | Lymphopenia (HP:0001888) | 2.69245099 |
| 67 | Colitis (HP:0002583) | 2.66930874 |
| 68 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.63919670 |
| 69 | Arterial thrombosis (HP:0004420) | 2.63226527 |
| 70 | IgA deficiency (HP:0002720) | 2.61220993 |
| 71 | Gastrointestinal infarctions (HP:0005244) | 2.57810236 |
| 72 | Hematochezia (HP:0002573) | 2.52762170 |
| 73 | Emphysema (HP:0002097) | 2.52417828 |
| 74 | Basal ganglia calcification (HP:0002135) | 2.51181345 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.49617064 |
| 76 | Genetic anticipation (HP:0003743) | 2.49001327 |
| 77 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.47763690 |
| 78 | Pulmonary embolism (HP:0002204) | 2.46480125 |
| 79 | Urticaria (HP:0001025) | 2.41342592 |
| 80 | Recurrent sinusitis (HP:0011108) | 2.33269245 |
| 81 | Hypoproteinemia (HP:0003075) | 2.31727754 |
| 82 | Porencephaly (HP:0002132) | 2.31118992 |
| 83 | Cheilitis (HP:0100825) | 2.28640983 |
| 84 | Alveolar cell carcinoma (HP:0006519) | 2.28051025 |
| 85 | Increased cerebral lipofuscin (HP:0011813) | 2.27043663 |
| 86 | Vertigo (HP:0002321) | 2.25687111 |
| 87 | Lymphoma (HP:0002665) | 2.25314534 |
| 88 | Hypochromic anemia (HP:0001931) | 2.23442887 |
| 89 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.21686394 |
| 90 | Gingival bleeding (HP:0000225) | 2.20120160 |
| 91 | Gingivitis (HP:0000230) | 2.19256560 |
| 92 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.19000053 |
| 93 | Gangrene (HP:0100758) | 2.16119569 |
| 94 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.13140942 |
| 95 | Abnormality of glycolipid metabolism (HP:0010969) | 2.10056000 |
| 96 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.10056000 |
| 97 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.10056000 |
| 98 | Gastrointestinal stroma tumor (HP:0100723) | 2.09072200 |
| 99 | Episodic fever (HP:0001954) | 2.05795753 |
| 100 | Bronchiectasis (HP:0002110) | 2.05737825 |
| 101 | Abnormality of the pericardium (HP:0001697) | 2.04089058 |
| 102 | Periodontitis (HP:0000704) | 2.01990302 |
| 103 | Epistaxis (HP:0000421) | 2.01372211 |
| 104 | Loss of speech (HP:0002371) | 2.00000017 |
| 105 | Keratitis (HP:0000491) | 1.99351423 |
| 106 | Malnutrition (HP:0004395) | 1.98967393 |
| 107 | Abnormality of the prostate (HP:0008775) | 1.98212215 |
| 108 | Skin ulcer (HP:0200042) | 1.96910325 |
| 109 | Chest pain (HP:0100749) | 1.96402374 |
| 110 | Cellulitis (HP:0100658) | 1.95790700 |
| 111 | Peritonitis (HP:0002586) | 1.94283679 |
| 112 | Acne (HP:0001061) | 1.93648831 |
| 113 | Interstitial pulmonary disease (HP:0006530) | 1.91852382 |
| 114 | Abnormality of the endocardium (HP:0004306) | 1.90150306 |
| 115 | Thrombocytosis (HP:0001894) | 1.89613092 |
| 116 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.86701919 |
| 117 | Sepsis (HP:0100806) | 1.83620517 |
| 118 | Amaurosis fugax (HP:0100576) | 1.79813801 |
| 119 | Prolonged bleeding time (HP:0003010) | 1.78319412 |
| 120 | Polyneuropathy (HP:0001271) | 1.77955259 |
| 121 | Anorexia (HP:0002039) | 1.75820487 |
| 122 | Recurrent pneumonia (HP:0006532) | 1.75647937 |
| 123 | Verrucae (HP:0200043) | 1.74130511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.49189015 |
| 2 | MAP4K1 | 4.82931137 |
| 3 | FGFR4 | 3.87360187 |
| 4 | IKBKE | 3.76180075 |
| 5 | TYK2 | 3.55464091 |
| 6 | JAK3 | 3.49766105 |
| 7 | FRK | 3.36193022 |
| 8 | MAP3K14 | 3.34157240 |
| 9 | JAK1 | 2.75447535 |
| 10 | TBK1 | 2.62631554 |
| 11 | FGFR3 | 2.47973511 |
| 12 | KIT | 2.35429505 |
| 13 | ZAP70 | 2.33551800 |
| 14 | ITK | 2.20573083 |
| 15 | MAP3K13 | 2.05867528 |
| 16 | BLK | 1.92178002 |
| 17 | MATK | 1.82928075 |
| 18 | EPHB1 | 1.80541166 |
| 19 | IRAK4 | 1.75093606 |
| 20 | IKBKB | 1.73870140 |
| 21 | CSK | 1.73424413 |
| 22 | ACVR1B | 1.66333385 |
| 23 | STK10 | 1.66215272 |
| 24 | LCK | 1.65656135 |
| 25 | NLK | 1.49811865 |
| 26 | TEC | 1.48911726 |
| 27 | SYK | 1.44651200 |
| 28 | MST4 | 1.41905662 |
| 29 | PRPF4B | 1.38136172 |
| 30 | SIK2 | 1.34506906 |
| 31 | HCK | 1.33572102 |
| 32 | RIPK1 | 1.33058822 |
| 33 | EPHA3 | 1.23469136 |
| 34 | IRAK3 | 1.23231073 |
| 35 | KDR | 1.23222518 |
| 36 | TIE1 | 1.22755663 |
| 37 | PRKCQ | 1.21771947 |
| 38 | GRK6 | 1.19396824 |
| 39 | CHUK | 1.19136995 |
| 40 | BTK | 1.16906934 |
| 41 | CDK19 | 1.16003186 |
| 42 | TGFBR2 | 1.13902213 |
| 43 | MAP2K3 | 1.00876108 |
| 44 | PIM1 | 0.99801349 |
| 45 | FES | 0.99177960 |
| 46 | JAK2 | 0.95588812 |
| 47 | TNK2 | 0.94129305 |
| 48 | CDC42BPA | 0.87279949 |
| 49 | MARK3 | 0.84856441 |
| 50 | PRKCH | 0.84435547 |
| 51 | OXSR1 | 0.83492175 |
| 52 | LYN | 0.83339758 |
| 53 | PIK3CG | 0.81919573 |
| 54 | DAPK2 | 0.80075318 |
| 55 | IRAK1 | 0.79108337 |
| 56 | CLK1 | 0.77933665 |
| 57 | PBK | 0.75371358 |
| 58 | TAOK2 | 0.73152364 |
| 59 | MAPK11 | 0.72484801 |
| 60 | CSF1R | 0.71943073 |
| 61 | MAP3K10 | 0.71662012 |
| 62 | MAP3K11 | 0.69809358 |
| 63 | CAMKK2 | 0.66935529 |
| 64 | TAOK1 | 0.65566235 |
| 65 | MAP3K3 | 0.65266843 |
| 66 | BMPR1B | 0.64223494 |
| 67 | MAP3K1 | 0.63684402 |
| 68 | RPS6KA5 | 0.63419110 |
| 69 | NME2 | 0.61518574 |
| 70 | PKN1 | 0.61502776 |
| 71 | MAP2K6 | 0.60401021 |
| 72 | LRRK2 | 0.59588108 |
| 73 | STK4 | 0.59109026 |
| 74 | RIPK4 | 0.58704592 |
| 75 | RPS6KA4 | 0.57113719 |
| 76 | DDR2 | 0.56975696 |
| 77 | TLK1 | 0.54780101 |
| 78 | MAP3K7 | 0.52793393 |
| 79 | MAPK12 | 0.51423357 |
| 80 | FGR | 0.50654590 |
| 81 | PTK6 | 0.48402863 |
| 82 | PDK1 | 0.47321869 |
| 83 | NEK6 | 0.45722443 |
| 84 | EIF2AK2 | 0.44534526 |
| 85 | TAOK3 | 0.42090798 |
| 86 | EGFR | 0.41874874 |
| 87 | TTN | 0.41338048 |
| 88 | INSR | 0.40712156 |
| 89 | PIK3CA | 0.36948763 |
| 90 | ABL1 | 0.36638318 |
| 91 | GRK1 | 0.36486306 |
| 92 | MAP3K5 | 0.36474814 |
| 93 | PDGFRB | 0.36166257 |
| 94 | FYN | 0.36112175 |
| 95 | GRK7 | 0.35956380 |
| 96 | HIPK2 | 0.35358124 |
| 97 | SIK3 | 0.35274667 |
| 98 | BMPR2 | 0.34524000 |
| 99 | TRPM7 | 0.34389707 |
| 100 | MAPK7 | 0.34171182 |
| 101 | PDPK1 | 0.33500527 |
| 102 | MELK | 0.33258626 |
| 103 | IGF1R | 0.32543583 |
| 104 | FER | 0.32420019 |
| 105 | PRKAA2 | 0.32314949 |
| 106 | PRKD2 | 0.32235994 |
| 107 | ADRBK2 | 0.32164309 |
| 108 | PRKCD | 0.30148883 |
| 109 | ADRBK1 | 0.29304024 |
| 110 | MAPK3 | 0.29249845 |
| 111 | SGK3 | 0.28983219 |
| 112 | MUSK | 0.28004146 |
| 113 | PIM2 | 0.27806369 |
| 114 | MARK2 | 0.27787398 |
| 115 | MAPK4 | 0.27204863 |
| 116 | IRAK2 | 0.26438271 |
| 117 | ERN1 | 0.25106462 |
| 118 | PTK2B | 0.24955816 |
| 119 | STK11 | 0.24651919 |
| 120 | RPS6KA6 | 0.23815364 |
| 121 | TYRO3 | 0.23814394 |
| 122 | GRK5 | 0.23780241 |
| 123 | YES1 | 0.23575246 |
| 124 | SGK2 | 0.22641617 |
| 125 | BMX | 0.21812672 |
| 126 | SRC | 0.21498616 |
| 127 | TGFBR1 | 0.21236858 |
| 128 | MAPKAPK2 | 0.19609862 |
| 129 | PRKG2 | 0.19391084 |
| 130 | PRKD1 | 0.19190151 |
| 131 | CDK4 | 0.18552919 |
| 132 | CDK12 | 0.17423950 |
| 133 | NUAK1 | 0.17402807 |
| 134 | PKN2 | 0.16116035 |
| 135 | CDK6 | 0.15933405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.97953155 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.35548617 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.01954662 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.00344254 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.99740944 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.98398589 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.97016970 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.78437855 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.48907340 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.46821233 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.44851163 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.35396981 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.29635927 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.28927557 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.18826321 |
| 16 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 2.05803390 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.98308927 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.94597724 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.89229224 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.76428045 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.69048846 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67891925 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.66389961 |
| 24 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.59787636 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.59321220 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.58421448 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.56310161 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.53651316 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.50204622 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.49825789 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.49729926 |
| 32 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.38042029 |
| 33 | Hepatitis C_Homo sapiens_hsa05160 | 1.29743918 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24758802 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.24401830 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21300426 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.20775074 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.19701467 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.18779887 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.16653724 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.16203234 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13085291 |
| 43 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.99702859 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.96457410 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96369571 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 0.92863709 |
| 47 | Legionellosis_Homo sapiens_hsa05134 | 0.91670185 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90794550 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83780479 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 0.83490107 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80510156 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78277597 |
| 53 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.77145799 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.74040497 |
| 55 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.72527407 |
| 56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70456947 |
| 57 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.70418802 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.69679925 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68922088 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67758310 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64196133 |
| 62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61648229 |
| 63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61544091 |
| 64 | ABC transporters_Homo sapiens_hsa02010 | 0.60200663 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58542539 |
| 66 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58015704 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50942384 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49558718 |
| 69 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48313716 |
| 70 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45340133 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44038596 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43948457 |
| 73 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41027143 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40547843 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40396085 |
| 76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39722546 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.38468998 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37579309 |
| 79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35950001 |
| 80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35850136 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35831069 |
| 82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35787044 |
| 83 | Lysosome_Homo sapiens_hsa04142 | 0.35783674 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.33183387 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32940544 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.32076708 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31550176 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31356207 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.30121335 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29572335 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.28706277 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27220810 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.26375063 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25404424 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25072907 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.24781373 |
| 97 | Pathways in cancer_Homo sapiens_hsa05200 | 0.24630229 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24629593 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.24465097 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23882560 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.23167269 |
| 102 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.22966979 |
| 103 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.22645892 |
| 104 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.21769148 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.20959950 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.19734174 |
| 107 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.19639245 |
| 108 | Other glycan degradation_Homo sapiens_hsa00511 | 0.19216979 |
| 109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.18883883 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.16310114 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16040739 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.15992165 |
| 113 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.15274557 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14837884 |
| 115 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.14603803 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.14528424 |
| 117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.14420605 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.13407771 |
| 119 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.11610979 |
| 120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.11564578 |
| 121 | Focal adhesion_Homo sapiens_hsa04510 | 0.09676744 |
| 122 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.09006837 |
| 123 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.08021289 |

